ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

WSJ BLOG/Health: A.M Vitals: "Good" Cholesterol Drug Fails; Alzheimer's and Depression Linked

(This story has been posted on The Wall Street Journal Online's Health Blog at By Christopher Weaver Roche Drug to Raise 'Good' Cholesterol Fails (WSJ): The drug's failure in a large human trial spelled a setback for pharmaceutical companies that see an opportunity in medicines that seek to ward of heart disease by raising so-called "good" cholesterol. Competitors Merck and Eli Lilly said they remain confident in late-stage drugs in their pipelines that work similarly. Study Examines Depression and Aging Brain (WSJ): The onset of depression late in life can be an early warning of Alzheimer's disease and other dementia later, according to a new study of 13,535 Kaiser Permanente members. A Regime's Tight Grip on AIDS (New York Times): Cuba's AIDS rate is only one-sixth that of the U.S., thanks in part to aggressive tactics taken in the early years of the epidemic, such as forced quarantines for people who tested positive for HIV. F.D.A. Staff Raises Concerns About Arthritis Drug (New York Times): Documents released ahead of a Food and Drug Administration review Wednesday show regulators are concerned a new Pfizer treatment for rheumatoid arthritis raised concerns of significant side-effects. Court Dismisses Vets' Suit on Mental Health Care (San Francisco Chronicle): A San Francisco appeals court dismissed a five-year-old suit by veterans groups accusing the Department of Veterans Affairs of delaying needed mental health services. Drug-Defying Germs from India Speed Post-Antibiotic Era (Bloomberg): The widespread use of antibiotics in India is helping cultivate new breeds of drug-resistant bacteria bred from otherwise benign microorganisms. -For continuously updated news from The Wall Street Journal, see at

Stock News for Merck (MRK)
10/06/201506:08:00Risultati dallo studio di fase 3 di MSD sulla terapia sperimentale...
10/05/201523:35:00MSD veröffentlicht Ergebnisse seiner Phase-3-Studie für Elbasvir/Grazoprevir, e...
10/05/201521:32:00Les résultats de l'étude de phase III de MSD sur le traitement e...
10/05/201519:01:00Results from Merck’s Phase 3 Study of Investigational Chronic H...
10/05/201519:01:00Results from MSD’s Phase 3 Study of Investigational Chronic H...
10/05/201517:15:00Merck Congratulates Awardees of 2015 Nobel Prize in Physiology...
10/02/201517:26:00FDA Approves Merck's Keytruda for Most Common Form of Lung Cancer...
10/02/201515:00:00FDA Approves Merck's Keytruda for Lung Cancer
10/02/201514:51:00FDA Approves Merck's Keytruda for Most Common Form of Lung Cancer
10/02/201514:49:00FDA Approves KEYTRUDA® (pembrolizumab) for the Treatment of...
10/01/201514:36:03Statement of Changes in Beneficial Ownership (4)
10/01/201514:36:03Statement of Changes in Beneficial Ownership (4)
10/01/201514:36:03Statement of Changes in Beneficial Ownership (4)
10/01/201514:36:03Statement of Changes in Beneficial Ownership (4)
10/01/201514:35:38Statement of Changes in Beneficial Ownership (4)
10/01/201509:44:00U.S. Hot Stocks: Hot Stocks to Watch
10/01/201508:00:00Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration...
10/01/201507:40:00BioMarin to Acquire Global Rights to the Drug Kuvan
10/01/201507:00:00NewLink Genetics Awarded $18 Million Contract Option from BARDA
09/29/201510:30:00International Coalition Urges Final Push to Eliminate River Blindness...

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations